文献速递泌尿生殖腹部MRUS

动态对比增强(DCE)成像对前列腺癌检出的增益取决于前列腺MRI阅片者经验

Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI.
PubMed 文献 · Clin Radiol · 2023-12-14

研究纳入124例接受3T多参数MRI(mpMRI)及MRI/超声融合靶向联合系统穿刺活检的患者,由低经验与高经验放射科医师分别盲法判读mpMRI与双参数MRI(bpMRI)。低经验者mpMRI敏感度79.3%、bpMRI 77.4%,高经验者mpMRI 98.1%、bpMRI 86.8%;高经验者mpMRI与bpMRI总体准确率无显著差异,但DCE有助于检出部分ISUP 2前列腺癌。

要点

  • 低经验者mpMRI与bpMRI敏感度分别为79.3%与77.4%,均漏诊相当比例临床显著前列腺癌。
  • 高经验者mpMRI敏感度98.1%,高于bpMRI的86.8%。
  • 高经验者mpMRI总体准确率87.1%与bpMRI 81.5%相比无显著差异(p=0.230)。

核心结论

  • 前列腺MRI的检出效能受益于阅片者经验;低经验者用mpMRI漏诊相当比例临床显著前列腺癌,用bpMRI漏诊更多;高经验者mpMRI与bpMRI总体效能相当,但DCE使部分ISUP 2前列腺癌得以检出。

研究设计与样本

  • 连续纳入2019年1月至9月接受3T mpMRI并随后行MRI/超声融合引导靶向联合系统穿刺活检的患者124例。

诊断标准与关键数值

  • 低经验阅片者(R1,前列腺MRI<500例)mpMRI检出临床显著前列腺癌的敏感度为79.3%(NPV 79.3%),bpMRI为77.4%(NPV 75.5%)。
  • 高经验阅片者(R2,前列腺MRI>5,000例)mpMRI检出临床显著前列腺癌的敏感度为98.1%(NPV 97.5%),bpMRI为86.8%(NPV 84.4%)。
  • 低经验阅片者mpMRI特异度为59.2%,bpMRI为52.1%;高经验阅片者mpMRI特异度为54.9%,bpMRI为53.5%。
  • 低经验阅片者mpMRI总体准确率79.8%,高于bpMRI的66.9%(p=0.017);高经验阅片者mpMRI总体准确率87.1%,与bpMRI的81.5%相比无显著差异(p=0.230)。
  • bpMRI与mpMRI的PI-RADS一致性在低经验阅片者为fair(κ=0.373),在高经验阅片者为moderate(κ=0.508)。

临床应用与阅片要点

  • 低经验阅片者用mpMRI评估时有11例临床显著前列腺癌被判为PI-RADS≤3(20.8%),用bpMRI时有12例(22.6%)。
  • 高经验阅片者用mpMRI评估时有1例临床显著前列腺癌被判为PI-RADS≤3(1.9%),用bpMRI时有6例(11.3%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the relevance of dynamic contrast enhanced imaging (DCE) within multiparametric magnetic resonance imaging (mpMRI) for the detection of clinically significant prostate cancer (csPC) depending on reader experience.

MATERIALS AND METHODS: Consecutive patients with 3 T mpMRI and subsequent combined MRI/ultrasound fusion-guided targeted and systematic biopsy from January to September 2019 were included. All mpMRI examinations were read separately by two less experienced (R1; <500 prostate MRI) and two expert radiologists (R2; >5,000 prostate MRI) in consensus and blinded re-read as biparametric MRI (bpMRI). The primary endpoint was the performance comparison of mpMRI versus bpMRI of R1 and R2.

RESULTS: Fifty-three of 124 patients had csPC (43%). The PI-RADS agreement of bpMRI and mpMRI was fair for R1 (κ = 0.373) and moderate for R2 (κ = 0.508). R1 assessed 11 csPC with PI-RADS ≤3 (20.8%) on mpMRI and 12 (22.6%) on bpMRI (R2: 1 [1.9%] and 6 [11.3%], respectively). Sensitivity for csPC of mpMRI was 79.3% (NPV 79.3%) for R1 and 98.1% (NPV 97.5%) for R2 (bpMRI: 77.4% [NVP 75.5%] and 86.8% [NPV 84.4%], respectively). Specificity of mpMRI for csPC was 59.2% for R1 and 54.9% for R2 (bpMRI: 52.1% and 53.5%, respectively). Overall accuracy of mpMRI was 79.8% for R1 compared to bpMRI 66.9% (p=0.017; R2: 87.1% and 81.5%; p=0.230).

CONCLUSION: Prostate MRI benefits from reader experience. Less experienced readers missed a relevant proportion of csPC with mpMRI and even more with bpMRI. The overall performance of expert readers was comparable for mpMRI and bpMRI but DCE enabled detection of some further ISUP 2 PC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ziayee F, Schimmöller L, Boschheidgen M, et al. Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI. Clin Radiol. 2023. PMID: 38185579. doi:10.1016/j.crad.2023.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。